Selected article for: "cardiogenic shock and observational study"

Author: Kiris, Tuncay; Avci, Eyüp; Ekin, Tuba; Akgün, Didar Elif; Tiryaki, Mücahit; Yidirim, Arafat; Hazir, Kutluhan; Murat, Bektaş; Yeni, Mehtap; Altindag, Rojhad; Gül, Sefa; Arik, Baran; Güzel, Tuncay; Murat, Selda; Oz, Ahmet; Karabacak, Mustafa; Aktas, Zihni; Yildirim, Tarik; Kilicaslan, Baris; Ergene, Asim Oktay
Title: Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry)
  • Cord-id: j6fo487e
  • Document date: 2021_5_29
  • ID: j6fo487e
    Snippet: OBJECTIVE: We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey. METHODS: This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st
    Document: OBJECTIVE: We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey. METHODS: This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st–May 15st, 2020; n = 733) or pre- COVID-19 era group (March 11st–May 15st, 2019; n = 1055). Also, the patients in COVID-19 era were grouped as COVID-19 positive (n = 65) or negative (n = 668). RESULTS: There was a 30.5% drop in STEMI admission during COVID-19 era in comparison to pre-COVID-19 era. The patients admitted to the medical centers during COVID-19 era had a longer symptom-to-first medical contact time [120 (75–240) vs. 100 (60–180) minutes, p < 0.001]. COVID-19 positive STEMI patients had higher thrombus grade and lower left ventricular ejection fraction compared to COVID-19 negative patients. COVID-19 positive patients had higher mortality (28% vs. 6%, p < 0.001) and cardiogenic shock (20% vs. 7%, p < 0.001) rates compared with those without COVID-19. Matching based on propensity scores showed higher mortality and high thrombus grade in STEMI patients who were infected by SARS-COV-2 (each p < 0.05). CONCLUSIONS: We detected significantly lower STEMI hospitalization rates and significant delay in duration of symptom onset to first medical contact in the context of Turkey during the COVID-19 outbreak. Moreover, high thrombus grade and mortality were more common in COVID-19 positive STEMI patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11239-021-02487-3.

    Search related documents:
    Co phrase search for related documents
    • absolute number and admission rate: 1, 2
    • absolute number and admission reduction: 1
    • absolute number and lymphocyte count: 1, 2, 3
    • ace arb angiotensin and acute coronary syndrome: 1
    • ace arb angiotensin and admission rate: 1
    • ace arb angiotensin and lymphocyte count: 1
    • acute coronary syndrome and admission rate: 1, 2, 3, 4, 5
    • acute coronary syndrome and admission reduction: 1, 2, 3
    • acute coronary syndrome and long term follow: 1, 2, 3, 4, 5
    • acute coronary syndrome and long term mortality: 1, 2, 3
    • acute coronary syndrome and lv left ventricle: 1
    • acute coronary syndrome and lymphocyte count: 1, 2
    • admission rate and long term follow: 1
    • admission rate and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • admission rate and lymphocyte count low: 1, 2, 3
    • admission reduction and long term follow: 1
    • admission reduction and long term mortality: 1, 2
    • admission reduction and lymphocyte count: 1, 2, 3, 4, 5
    • long term follow and lv left ventricle: 1